Literature DB >> 27371030

Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia.

Chijioke N Egbujo1, Duncan Sinclair2, Chang-Gyu Hahn3.   

Abstract

Schizophrenia is a serious psychiatric illness which is experienced by about 1 % of individuals worldwide and has a debilitating impact on perception, cognition, and social function. Over the years, several models/hypotheses have been developed which link schizophrenia to dysregulations of the dopamine, glutamate, and serotonin receptor pathways. An important segment of these pathways that have been extensively studied for the pathophysiology of schizophrenia is the presynaptic neurotransmitter release mechanism. This set of molecular events is an evolutionarily well-conserved process that involves vesicle recruitment, docking, membrane fusion, and recycling, leading to efficient neurotransmitter delivery at the synapse. Accumulated evidence indicate dysregulation of this mechanism impacting postsynaptic signal transduction via different neurotransmitters in key brain regions implicated in schizophrenia. In recent years, after ground-breaking work that elucidated the operations of this mechanism, research efforts have focused on the alterations in the messenger RNA (mRNA) and protein expression of presynaptic neurotransmitter release molecules in schizophrenia and other neuropsychiatric conditions. In this review article, we present recent evidence from schizophrenia human postmortem studies that key proteins involved in the presynaptic release mechanism are dysregulated in the disorder. We also discuss the potential impact of dysfunctional presynaptic neurotransmitter release on the various neurotransmitter systems implicated in schizophrenia.

Entities:  

Keywords:  Complexin; Munc18; Neurotransmitter; Presynaptic; SNAP-25 (synaptosomal-associated protein 25); SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor); Schizophrenia; Synapsin; Synaptobrevin; Synaptophysin; Syntaxin

Mesh:

Substances:

Year:  2016        PMID: 27371030      PMCID: PMC5134737          DOI: 10.1007/s11920-016-0710-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  76 in total

Review 1.  The synapsins: key actors of synapse function and plasticity.

Authors:  F Cesca; P Baldelli; F Valtorta; F Benfenati
Journal:  Prog Neurobiol       Date:  2010-05-10       Impact factor: 11.685

2.  A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients.

Authors:  C Imai; T Sugai; S Iritani; K Niizato; R Nakamura; T Makifuchi; A Kakita; H Takahashi; H Nawa
Journal:  Neurosci Lett       Date:  2001-06-15       Impact factor: 3.046

3.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

4.  Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.

Authors:  P M Thompson; A C Sower; N I Perrone-Bizzozero
Journal:  Biol Psychiatry       Date:  1998-02-15       Impact factor: 13.382

5.  Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia.

Authors:  Mikael Landén; Pia Davidsson; Carl-Gerhard Gottfries; Jan-Eric Månsson; Kaj Blennow
Journal:  Schizophr Res       Date:  2002-05-01       Impact factor: 4.939

6.  Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.

Authors:  Jessie S Chambers; Deirdre Thomas; Linda Saland; Rachael L Neve; Nora I Perrone-Bizzozero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-12-24       Impact factor: 5.067

7.  Common mechanisms for regulated exocytosis in the chromaffin cell and the synapse.

Authors:  A Morgan; R D Burgoyne
Journal:  Semin Cell Dev Biol       Date:  1997-04       Impact factor: 7.727

8.  SNAP receptors implicated in vesicle targeting and fusion.

Authors:  T Söllner; S W Whiteheart; M Brunner; H Erdjument-Bromage; S Geromanos; P Tempst; J E Rothman
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

9.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Karin E Borgmann-Winter; Steven E Arnold; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2015-08-07       Impact factor: 4.939

10.  Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.

Authors:  Jan Lochman; Vladimir J Balcar; František Sťastný; Omar Serý
Journal:  Psychiatry Res       Date:  2012-08-30       Impact factor: 3.222

View more
  23 in total

1.  Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain.

Authors:  Alfredo Ramos-Miguel; Kristina Gicas; Jehan Alamri; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Fang Cai; Weihong Song; Alasdair M Barr; William G Honer
Journal:  Neuroscience       Date:  2018-12-21       Impact factor: 3.590

2.  Complexin I knockout rats exhibit a complex neurobehavioral phenotype including profound ataxia and marked deficits in lifespan.

Authors:  Yang Xu; Xiao-Ming Zhao; Jia Liu; Yang-Yang Wang; Liu-Lin Xiong; Xiu-Ying He; Ting-Hua Wang
Journal:  Pflugers Arch       Date:  2019-12-24       Impact factor: 3.657

3.  Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.

Authors:  Stephanie J Temme; Brady J Maher; Kimberly M Christian
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

4.  The promises and challenges of human brain organoids as models of neuropsychiatric disease.

Authors:  Giorgia Quadrato; Juliana Brown; Paola Arlotta
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

5.  The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1.

Authors:  Alfredo Ramos-Miguel; Vilte Barakauskas; Jehan Alamri; Masatoshi Miyauchi; Alasdair M Barr; Clare L Beasley; Gorazd Rosoklija; J John Mann; Andrew J Dwork; Annie Moradian; Gregg B Morin; William G Honer
Journal:  Neuroscience       Date:  2019-01-02       Impact factor: 3.590

6.  Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility.

Authors:  Daniel M Fass; Michael C Lewis; Rushdy Ahmad; Matthew J Szucs; Qiangge Zhang; Morgan Fleishman; Dongqing Wang; Myung Jong Kim; Jonathan Biag; Steven A Carr; Edward M Scolnick; Richard T Premont; Stephen J Haggarty
Journal:  Mol Psychiatry       Date:  2022-05-03       Impact factor: 15.992

Review 7.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

8.  CUL3 Deficiency Causes Social Deficits and Anxiety-like Behaviors by Impairing Excitation-Inhibition Balance through the Promotion of Cap-Dependent Translation.

Authors:  Zhaoqi Dong; Wenbing Chen; Chao Chen; Hongsheng Wang; Wanpeng Cui; Zhibing Tan; Heath Robinson; Nannan Gao; Bin Luo; Lei Zhang; Kai Zhao; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2019-11-25       Impact factor: 17.173

9.  Synaptotagmin-7 is a key factor for bipolar-like behavioral abnormalities in mice.

Authors:  Wei Shen; Qiu-Wen Wang; Yao-Nan Liu; Maria C Marchetto; Sara Linker; Si-Yao Lu; Yun Chen; Chuihong Liu; Chongye Guo; Zhikai Xing; Wei Shi; John R Kelsoe; Martin Alda; Hongwei Wang; Yi Zhong; Sen-Fang Sui; Mei Zhao; Yiming Yang; Shuangli Mi; Liping Cao; Fred H Gage; Jun Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-10       Impact factor: 11.205

10.  Abnormally Increased Secretion in Olfactory Neuronal Precursors from a Case of Schizophrenia Is Modulated by Melatonin: A Pilot Study.

Authors:  Montserrat G Cercós; Tania Galván-Arrieta; Marcela Valdés-Tovar; Héctor Solís-Chagoyán; Jesús Argueta; Gloria Benítez-King; Citlali Trueta
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.